NEW YORK Weakness in the health care and technology sectors dragged the U.S. stock market lower. <\/p>\n
Health care stocks, which have risen more than other industries over the past year, fell sharply on Monday. <\/p>\n
Pfizer had the biggest loss in the Dow Jones industrial average, 2 percent. Biotech stocks continued a decline that began Friday after lawmakers questioned the pricing of a Hepatitis C drug. <\/p>\n
The Standard & Poor's 500 index fell nine points, or 0.5 percent, to close at 1,857. <\/p>\n
The Dow lost 26 points, or 0.2 percent, to 16,276. <\/p>\n
The technology-heavy Nasdaq composite fell 50 points, or 1.2 percent, to 4,226. <\/p>\n
Facebook, which has more than doubled over the past year, fell 5 percent. <\/p>\n
Bond prices rose. The yield on the 10-year Treasury note fell to 2.73 percent. <\/p>\n
Health care stocks, which have risen more than other industries over the past year, fell sharply on Monday. <\/p>\n
Pfizer had the biggest loss in the Dow Jones industrial average, 2 percent. Biotech stocks continued a decline that began Friday after lawmakers questioned the pricing of a Hepatitis C drug. <\/p>\n
<\/p>\n
See more here: <\/p>\n
UPDATE: Health Care, Tech Names Lead Decline in U.S. Stocks<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" NEW YORK Weakness in the health care and technology sectors dragged the U.S. stock market lower. Continue reading